WestEnd Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.9K | Buy |
11
+1
| +10% | +$445 | ﹤0.01% | 104 |
|
|
2025
Q1 | $4.85K | Buy |
10
+7
| +233% | +$3.39K | ﹤0.01% | 98 |
|
|
2024
Q4 | $1.21K | Hold |
3
| – | – | ﹤0.01% | 119 |
|
|
2024
Q3 | $1.4K | Hold |
3
| – | – | ﹤0.01% | 108 |
|
|
2024
Q2 | $1.41K | Sell |
3
-1
| -25% | -$469 | ﹤0.01% | 100 |
|
|
2024
Q1 | $1.67K | Hold |
4
| – | – | ﹤0.01% | 94 |
|
|
2023
Q4 | $1.63K | Hold |
4
| – | – | ﹤0.01% | 97 |
|
|
2023
Q3 | $1.39K | Buy |
+4
| New | +$1.39K | ﹤0.01% | 93 |
|
|
2023
Q2 | – | Hold |
0
| – | -$945 | – | 287 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$866 | – | 110 |
|
|
2022
Q4 | $866 | Hold |
3
| – | – | ﹤0.01% | 106 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 134 |
|
|
2022
Q2 | $845 | Buy |
+3
| New | +$845 | ﹤0.01% | 117 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$439 | – | 147 |
|
|
2021
Q4 | $439 | Buy |
+2
| New | +$439 | ﹤0.01% | 165 |
|
|
2021
Q3 | – | Hold |
0
| – | -$403K | – | 167 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 167 |
|